By Indiana Right to Life
As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk.
The rate of abortion-related emergency room visits following a chemical abortion increased over 500% from 2002 through 2015, according to an analysis of Medicaid claims data. Over the same period, chemical abortions within the study population increased from 4.4% to 34.1% of total abortions.
CLI scholars also discovered that by 2015, a majority of these emergency room visits were miscoded as spontaneous miscarriages, potentially putting patients at risk and masking the true dangers of chemical abortion.
Dr. James Studnicki, CLI vice president of data analytics, explained:
“The safety of chemical abortion is greatly exaggerated. In fact, the increasing dominance of chemical abortion and its disproportionate contribution to emergency room morbidity is a serious public health threat, and the real-world data suggests the threat is growing.
“Women are far more likely to visit the emergency room following a chemical rather than surgical abortion. The rate of these emergency room visits is growing remarkably fast. It is therefore terrifying that the FDA is actively being pressured to eliminate longstanding public health safeguards on the abortion pill. This comprehensive data advocates for the FDA to strengthen, rather than weaken, medical oversight of chemical New Study.”